Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors.

Date publication

août 2017

Journal

Clinical genitourinary cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr LADOIRE Sylvain

Tous les auteurs :
Ramos JD, Wingate JT, Gulati R, Plimack ER, Harshman LC, Powles T, Crabb SJ, Niegisch G, Bellmunt J, Ladoire S, De Giorgi U, Hussain S, Alva AS, Baniel J, Agarwal N, Rosenberg JE, Vaishampayan UN, Galsky MD, Yu EY,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28923700

Résumé

Venous thromboembolism (VTE) is common in cancer patients, but there is limited data on patients with urothelial tract tumors (UTT). We previously identified several associative factors for increased VTE rates in patients with metastatic UTT. In this study, we assessed the frequency, associative factors, and impact on survival of VTE in patients with locoregional UTT.

Mots clés

Bladder cancer, Localized, Metastatic, Non-urothelial, Thrombosis

Référence

Clin Genitourin Cancer. 2017 Aug;: